Harbin Sanlian Pharmaceutical Co., Ltd. (hereinafter referred to as "Harbin Sanlian") is a high-tech enterprise specializing in the research and development, production and sales of chemical pharmaceutical preparations.

       The company was founded in 1996. In 2001, freeze-dried powder injections, small-volume injections, and large-volume injections passed the national GMP certification at one time. The production capacity of the company has been rapidly improved, and the economic benefits have been rapidly improved.

       Since 2011, the company has established the Harbin Sanlian Pharmaceutical Research Institute on the basis of group operation, and completed the shareholding system reform in 2013. It was successfully listed on the Shenzhen Stock Exchange on September 22, 2017.

       The company adopts modern management concepts and adheres to the principle of ho...